Clincosm LogoSign in Get a demo

SARS-CoV-2 Infection

Showing NaN - NaN of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19, SARS-CoV-2 Infection, Coronavirus Infection Trial in United States (TXA127, TRV027, Placebo)

Recruiting
  • COVID-19
  • +2 more
  • Birmingham, Alabama
  • +68 more
Jan 24, 2023

SARS-CoV-2 Infection Trial in United States (Moderna COVID-19 Vaccine)

Completed
  • SARS-CoV-2 Infection
  • Moderna COVID-19 Vaccine
  • Birmingham, Alabama
  • +50 more
Dec 1, 2022

SARS-CoV-2 Infection, Acute Kidney Injury Trial in New York, San Antonio, Seattle (Placebo, Nicotinamide riboside)

Active, not recruiting
  • SARS-CoV-2 Infection
  • Acute Kidney Injury
  • Placebo
  • Nicotinamide riboside
  • New York, New York
  • +3 more
Oct 25, 2022

ImmuneSense™ COVID-19 Cross-Reactivity Study

Suspended
  • Coronavirus Disease
  • SARS-CoV-2 Infection
    • Seattle, Washington
      Adaptive Biotechnologies
    Aug 3, 2022

    SARS-CoV-2 Infection, COVID-19 Trial in Worldwide (BNT162b2, Placebo, BNT162b2 OMI)

    Recruiting
    • SARS-CoV-2 Infection
    • COVID-19
    • BNT162b2
    • +4 more
    • Athens, Alabama
    • +158 more
    Jul 18, 2022

    COVID-19 Observational Research Collaboratory

    Enrolling by invitation
    • COVID-19
    • SARS-CoV-2 Infection
      • West Haven, Connecticut
      • +5 more
      May 25, 2022

      Index Individuals in SARS-CoV-2 Prevention Research Studies

      Completed
      • SARS-CoV-2 Infection
      • +3 more
        • Seattle, Washington
          University of Washington International Clinical Research Center
        Dec 6, 2021